Brokerage Firm Analyst Consensus on Noble Energy Inc. (NYSE:NBL), Amgen Inc. (NASDAQ:AMGN)

For the current quarter, analysts are expecting Noble Energy Inc. (NYSE:NBL) to report EPS of $-0.13. This consensus estimate is provided by Zacks Research. After the period that ended on 2016-12-31, Noble Energy Inc. (NYSE:NBL) reported an EPS actual of $0.26. The difference between the actual and estimate resulted in a surprise factor of 388.89%. The company is expected to release their next earnings report on or around 2017-05-01. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.

Shares of Noble Energy Inc. (NYSE:NBL) have a current ABR or average broker rating of 1.84. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.

Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Noble Energy Inc. (NYSE:NBL) is $45.684. The top analyst target is $53, and the lowest target is $36 on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.

For the current quarter, analysts are expecting Amgen Inc. (NASDAQ:AMGN) to report EPS of $3.07. This consensus estimate is provided by Zacks Research. After the period that ended on 2017-03-31, Amgen Inc. (NASDAQ:AMGN) reported an EPS actual of $3.15. The difference between the actual and estimate resulted in a surprise factor of 5%. The company is expected to release their next earnings report on or around 2017-07-26. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.

Shares of Amgen Inc. (NASDAQ:AMGN) have a current ABR or average broker rating of 2.28. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.

Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Amgen Inc. (NASDAQ:AMGN) is $181.909. The top analyst target is $209, and the lowest target is $160 on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.

Leave a Comment